The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

* Kroger is working with its merchandising and sourcing teams to diversify the supplier base for some commodities in its ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

Corporate America is scrambling to implement countermeasures as President Donald Trump's latest tariffs on Chinese imports ...

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance.

Experts have warned that additional levies will only serve to push up prices in the already costly U.S. healthcare sector.

Trump looks forward to such things, but he has made the situation quite complicated for the citizens of his country.

Trade groups are urging the administration to consider the impact on patient care and are pushing for exemptions to the tariffs. Also in the news: Pfizer might move production to the U.S. to combat ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Shares ChatGPT’s Flaws. In this article, we are ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...